(DBX1) Xtrackers - MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292107645 • Global Emerging Markets Equity
DBX1: Emerging Markets, Equities, Stocks
The Xtrackers - MSCI Emerging Markets Swap UCITS ETF (Ticker: DBX1) is a German-domiciled exchange-traded fund designed to provide exposure to emerging markets equities. Listed on XETRA, it is structured as a swap-based ETF, utilizing derivatives to replicate the performance of its target index, the Morningstar EM TME NR USD. This index tracks the performance of equities in emerging markets, offering a broad representation of companies across various regions and sectors.
With assets under management (AUM) of 732.57 million EUR, this ETF is a sizable fund, indicating significant investor interest in its emerging markets exposure. The funds swap-based structure allows it to efficiently track the underlying index while managing tracking error. As a UCITS-compliant ETF, it adheres to European regulatory standards, ensuring transparency and investor protection. Additional information on the fund can be accessed through the issuers website at http://www.dws.lu.
Looking ahead, the future outlook for the Xtrackers - MSCI Emerging Markets Swap UCITS ETF will likely hinge on the broader trends in emerging markets. As these economies continue to grow, albeit with inherent volatility, the fund stands to benefit from increasing investor appetite for higher returns in less developed regions. However, factors such as geopolitical risks, currency fluctuations, and economic policy changes could impact performance. The ETFs ability to maintain its tracking efficiency and control costs will remain critical in maintaining its appeal to investors seeking diversified exposure to emerging markets.
Additional Sources for DBX1 ETF
DBX1 ETF Overview
Market Cap in USD | 794m |
Category | Global Emerging Markets Equity |
TER | 0.49% |
IPO / Inception | 2007-06-22 |
DBX1 ETF Ratings
Growth 5y | 42.2% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -13.7 |
Analysts | - |
Fair Price Momentum | 45.54 EUR |
Fair Price DCF | - |
DBX1 Dividends
No Dividends PaidDBX1 Growth Ratios
Growth Correlation 3m | 23.9% |
Growth Correlation 12m | 80.5% |
Growth Correlation 5y | 23.1% |
CAGR 5y | 8.82% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.92 |
Alpha | 2.09 |
Beta | 0.65 |
Volatility | 20.10% |
Current Volume | 8.5k |
Average Volume 20d | 5.6k |
As of March 13, 2025, the stock is trading at EUR 49.00 with a total of 8,497 shares traded.
Over the past week, the price has changed by -1.41%, over one month by -4.36%, over three months by -2.80% and over the past year by +8.43%.
Partly, yes. Based on ValueRay Analyses, Xtrackers - MSCI Emerging (XETRA:DBX1) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 42.19 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBX1 as of March 2025 is 45.54. This means that DBX1 is currently overvalued and has a potential downside of -7.06%.
Xtrackers - MSCI Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, DBX1 Xtrackers - MSCI Emerging will be worth about 50.5 in March 2026. The stock is currently trading at 49.00. This means that the stock has a potential upside of +3.06%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 50.5 | 3.1% |